All In Biotech

Drug Trial Radar · NCT06959095

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

A Randomized, Double-Blind, Placebo- Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Depemokimab In Adult Participants With COPD With Type 2 Inflammation

Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 981 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

981

Planned (sponsor's estimate)

Start

Jun 20, 2025

Primary completion

Dec 13, 2028

Study completion Feb 14, 2029

Sponsor

Lead sponsor
GlaxoSmithKlineGSK (GSK)
Sponsor type
Industry
First posted
May 6, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Depemokimab is being developed as a treatment for individuals with moderate to severe COPD. The aim of this study is to assess the efficacy and safety of depemokimab as an add-on medicine in participants with uncontrolled moderate to severe COPD with type 2 inflammation.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

  • DepemokimabBiological

    Depemokimab as a sterile liquid formulation will be administered.

  • PlaceboDrug

    Placebo as a sterile 0.9 percent (%) sodium chloride solution will be administered.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Annualized Rate of Moderate/Severe ExacerbationsTime frame: From Baseline up to Week 104

Locations

281 sites in 23 countries. Site status is shown where the registry gives one.

  • GSK Investigational Site

    Bakersfield, California · Recruiting

  • GSK Investigational Site

    Modesto, California · Recruiting

  • GSK Investigational Site

    Newport Beach, California · Recruiting

  • GSK Investigational Site

    Wilmington, Delaware · Recruiting

  • GSK Investigational Site

    Bradenton, Florida · Recruiting

  • GSK Investigational Site

    Brandon, Florida · Recruiting

  • GSK Investigational Site

    Hialeah, Florida · Recruiting

  • GSK Investigational Site

    Hialeah, Florida · Recruiting

  • GSK Investigational Site

    Loxahatchee Groves, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami Lakes, Florida · Recruiting

  • GSK Investigational Site

    Orange City, Florida · Recruiting

  • GSK Investigational Site

    Palm Springs, Florida · Recruiting

  • GSK Investigational Site

    Palmetto Bay, Florida · Recruiting

  • GSK Investigational Site

    Pensacola, Florida · Recruiting

  • GSK Investigational Site

    Tamarac, Florida · Recruiting

  • GSK Investigational Site

    Tampa, Florida · Recruiting

  • GSK Investigational Site

    The Villages, Florida · Recruiting

  • GSK Investigational Site

    Riverdale, Georgia · Recruiting

  • GSK Investigational Site

    Stonecrest, Georgia · Recruiting

  • GSK Investigational Site

    Chicago, Illinois · Recruiting

  • GSK Investigational Site

    Baltimore, Maryland · Recruiting

  • GSK Investigational Site

    Clarkston, Michigan · Recruiting

  • GSK Investigational Site

    Flint, Michigan · Recruiting

  • GSK Investigational Site

    St Louis, Missouri · Recruiting

  • GSK Investigational Site

    Henderson, Nevada · Recruiting

  • GSK Investigational Site

    Las Vegas, Nevada · Recruiting

  • GSK Investigational Site

    Reno, Nevada · Recruiting

  • GSK Investigational Site

    North Massapequa, New York · Recruiting

  • GSK Investigational Site

    Winston-Salem, North Carolina · Recruiting

  • GSK Investigational Site

    Winston-Salem, North Carolina · Recruiting

  • GSK Investigational Site

    Greenville, South Carolina · Recruiting

  • GSK Investigational Site

    Rock Hill, South Carolina · Recruiting

  • GSK Investigational Site

    Franklin, Tennessee · Recruiting

  • GSK Investigational Site

    Corsicana, Texas · Recruiting

  • GSK Investigational Site

    Dallas, Texas · Recruiting

  • GSK Investigational Site

    Houston, Texas · Recruiting

  • GSK Investigational Site

    Houston, Texas · Recruiting

  • GSK Investigational Site

    Houston, Texas · Recruiting

Showing 40 of 281 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.